A Pilot Trial of One-Day Accelerated TMS and D-cycloserine in Suicidal Patients With Borderline Personality Disorder

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Borderline Personality Disorder (BPD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

McLean Hospital, Belmont, Massachusetts, United States
Contact: Study coordinator (Alexandra L Velev, BA) · avelev@mclean.harvard.edu
Contact: Study coordinator (Molly Coyle, BS) · mcoyle3@mgb.org
Joshua C Brown, MD PhD (Sub-investigator)
Contact: Principal Investigator (Jenna M Traynor, PhD)

Study leads

Jenna M Traynor, PhD
Principal Investigator
Mclean Hospital
Joshua Brown, MD, PhD
Principal Investigator
Mclean Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Treatment of Borderline Personality Disorder With rTMS

Borderline Personality Disorder · Borderline Personality · BPD - Borderline Personality Disorder

Abroad (travel likely)Recruiting

Los Angeles, United States · Los Angeles, United States

Affect-based Impulsivity in Borderline Personality Disorder

Borderline Personality Disorder (BPD) · Healthy Controls Group - Age and Sex-matched

Abroad (travel likely)Recruiting

Chapel Hill, United States

Conceptualizing Borderline Personality Disorder as a Relationship Use Disorder

Borderline Personality Disorder · Borderline Personality Disorder (BPD) · Bipolar Disorder (BD)

Abroad (travel likely)Recruiting

Montpellier, France

The Role of Gender in Borderline Personality Disorder

Borderline Personality Disorder (BPD)

Abroad (travel likely)Recruiting

Heidelberg, Germany